TY  - THES
AB  - Different spectroscopic methods (FTIR, CD, NMR) have been used to study the conformational properties of cyclic hexa-, penta-, and tetrapeptides, with or without [beta]-homoproline, and to examine the influence of this [beta]-amino acid on the peptide conformation in different solvents. Combination of these three analytical techniques revealed that [beta]-homoproline is an excellent inducer of secondary structure when inserted into a cyclic peptide. This residue stabilizes a pseudo-[gamma]-turn, or less frequently a pseudo-[beta]-turn.
Twenty new cyclic peptides that mimic the VCAM-1 binding epitope (R36TQID40SPLN44) have been synthesized using Fmoc chemistry and cyclization in solution. D-amino acids, [beta]-amino acids and proline are used as secondary structure inducers for the spatial screening of the pharmacophoric groups. These peptides, designed as [alpha]4[beta]1 integrin antagonists, could have numerous medical applications and might be very useful in future studies of cell-cell and cell-extracellular matrix interactions.
A new method for cyclization in solution using two injection pumps for separate addition of peptide and coupling reagent solutions to the reaction mixture and a purification by precipitation extraction method was developed. Combination of these two methods allows any solvent to be used for peptide cyclization. HOAt as additive, a rational design of the linear peptide precursor and slow addition rate of the peptide solution to the reaction mixture suppresses dimerization and epimerization, the main side reactions of the cyclization. A [beta]-homoamino acid in a central position of the linear precursor enhances the cyclization rate, and suppresses dimerization by bringing the peptide in a proper conformation.
Two cyclic constrained peptide mimics of the invasin binding epitope in which D-amino acids were designed to lock the peptide conformation in such a way that the critical Asp residue occurs in i+1 position of the [beta]-turn were synthesized. The adhesion test shows that these peptides bind to [alpha]3[beta]1 integrin with low affinity (mM range) and inhibit binding of laminin-5 to the integrin. The third peptide is a combination of a cyclic hexapeptide with the SDMS sequence with an arginine residue connected via a linker to mimic the synergistic activity of Arg883 located 30 Å apart from the binding epitope. This peptide completely suppresses the binding of laminin-5 to the [alpha]3[beta]1 integrin and the IC50 value is in the µM range.
Five new RGD peptides were synthesized and tested as inhibitors of the interaction between OV-MZ-6 carcinoma cells with three different extracellular matrix proteins (vitronectin, fibronectin and collagen typ I). Two of them show very strong inhibitor activity toward interaction of [alpha]v[beta]3 with vitronectin.
Linear peptides with a C-terminal thioester are key intermediates for enzymatic macrocyclization using peptide synthetases. These precursors were synthesized on Kenner's sulfonamide "safety-catch" linker. N-acetylcysteamine is used for nucleophilic displacement and cleavage of the peptides from the activated linker. Cyclizations of linear precursors of the antibiotic tyrocidine A and its analogs proceed smoothly and with negligible rate of hydrolysis using isolated and purified TycC TE domain.
DA  - 2002
KW  - Cyclopeptide , Konformation , Lösungsmittel , Zirkulardichroismus , NMR-Spektroskopie , FT-IR-Spektroskopie , Aminosäuren (beta-) , Cyclisation , Peptidsynthese , [beta]-Amino acids , Integrin , VCAM-1 (Vascular cell adhesion molecule-1) , Invasin
LA  - eng
PY  - 2002
TI  - [beta]-Amino acids as secondary structure inducers in peptides
UR  - https://nbn-resolving.org/urn:nbn:de:hbz:361-2307
Y2  - 2024-11-24T06:51:12
ER  -